Pineapple gel approved for burns


A topical gel based on pineapple enzymes has been approved in the EU for use in the treatment of burns.

NexoBrid gel from privately owned biotech MediWound, contains proteolytic enzymes from the stem of the pineapple plant. It is the first pharmacological treatment for the removal of scab tissue associated with severe burns, which are typically removed surgically. Removal of scab tissue is essential to speed the healing process and prevent infection.

NexoBrid gel was designated an orphan medicine in 2002. Israeli generics giants Teva paid $163 million to raise its stake in Mediwound from 14% to 51% in 2010, according to Reuters.


Related Content

Traits not technology should govern EU GM laws, MPs say

27 February 2015 News and Analysis

news image

UK science and technology committee says European rules are flawed and need changing

Myelofibrosis drug approved in EU

28 August 2012 Business

news image

Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow

Most Read

Women twice as likely to be hired for academic posts as men

17 April 2015 News and Analysis

news image

Experiment shows that faculty staff are more likely to pick women for job roles based on hypothetical CVs

Carbon nanotube-based sensor detects meat spoilage

23 April 2015 Research

news image

Electron density of cobalt porphyrin complexes key to meat freshness sensor

Most Commented

Oh, the humanities!

20 April 2015 The Crucible

news image

Science and the arts are equally essential to society, says Philip Ball. Don’t divide them by their differences

Relativity behind mercury's liquidity

21 June 2013 Research

news image

First evidence that relativistic effects are indeed responsible for mercury's low melting point